๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Zhoukou
Clinical trial register · China

Clinical Trials in Zhoukou, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Zhoukou

12 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Treatment of Chinese Adult Subjects With Moderate to Severe Crohn's Disease With Tabellviยฎ
NCT07663526Crohn's Disease
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 4
50
Fuyang, Zhengzhou, Zhoukou, Huaian, Yancheng, Meihekou, Shanghai
2026-08
Recruiting
Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Posterior Circulation Large Vessel Occlusion Stroke
NCT07509645Ischemic Stroke
Capital Medical University
Phase 3
348
Suzhou, Anyang, Nanyang, Xinxiang, Zhoukou, Linyi, Zibo, Xianyang
2026-04-22
Not yet open
Comparison of Radiofrequency Ablation With Concomitant or Staged Treatment for Tributary Varicose Veins
NCT07445425Varicose Veins of Lower Limb
Sir Run Run Shaw Hospital
Not applicable
206
Bengbu, Beijing, Nanning, Haikou, Zhengzhou, Zhoukou, Chenzhou, Huai'an
2026-03
Recruiting
Low-Dose Tenecteplase for Acute Ischemic Stroke Treatment in Aging Patients
NCT07294209Acute Ischemic Stroke Patients
Southwest Hospital, China
Phase 4
798
Chongqing, Harbin, Zhoukou, Anshan, Anyang, Baoshan, Bijie, Dali
2025-12-19
Active, closed
Efficacy and Safety of Home-based Structured Physical Exercise in Patients With Acute Ischemic Stroke
NCT07271082Acute Ischemic Stroke
Capital Medical University
Not applicable
208
Fuyang, Suzhou, Beijing, Zhoukou, Shihezi
2025-12-18
Recruiting
AI Facial Analysis Algorithm to Screening Coronary Artery Disease in High-Risk Community Population
NCT07277686Coronary Artery Disease (CAD), Artificial Intelligence Algorithms, Face, Screening
China National Center for Cardiovascular Diseases
Observational
1,392
Zhoukou, Beijing
2025-12-11
Not yet open
The Treatment of Unresectable Liver Cancer With E-TACE Combined With Donafenib๏ผšA Prospective, Single-arm, Multicenter, Observational Study
NCT07180459Carcinoma, Hepatocellular Carcinoma
Xuhua Duan
Observational
118
Guiyang, Haikou, Kaifeng, Luohe, Luoyang, Nanyang, Shangqiu, Zhoukou
2025-10-10
Recruiting
Tirofiban With Sequential Dual Antiplatelet Therapy in Mild Stroke
NCT07095790Mild Stroke
Second Affiliated Hospital of Soochow University
Phase 4
580
Suzhou, Shijiazhuang, Zhoukou, Bayan Nur, Huai'an, Suqian, Taizhou, Xi'an
2025-08-30
Not yet open
A Prospective, Multicenter, Phase II Clinical Study on the Treatment of Unresectable Advanced HCC with DEB-TACE Combined with SALOX-HAIC
NCT06823050Hepatocellular Carcinoma
Xuhua Duan
Observational
59
Dengzhou, Jiaozuo, Kaifeng, Luoyang, Shangqiu, Zhengzhou, Zhoukou
2025-03-01
Recruiting
Efficacy and Safety of Linperlisib in Relapsed/Refractory Large Granular T Lymphocytic Leukemia
NCT06224257Relapsed/Refractory Large Granular T Lymphocytic Leukemia
Institute of Hematology & Blood Diseases Hospital, China
Phase 2
41
Hefei, Zhoukou, Tianjin
2023-12-03
Recruiting
Efficacy of Placebo Versus Chlorpheniramine for the Prevention of Allergic Transfusion Reactions.
NCT04688736Allergic Transfusion Reaction
Institute of Hematology & Blood Diseases Hospital, China
Phase 2
6,642
Hefei, Zhoukou, Taiโ€™an, Tianjin
2021-01-01
Active, closed
The Safety and Efficacy of Ibrutinib in Refractory/Relapsed Autoimmune Hemolytic Anemia
NCT04398459Refractory/Relapsed Autoimmune Hemolytic Anemia
Institute of Hematology & Blood Diseases Hospital, China
Phase 2
18
Zhoukou, Taiโ€™an, Tianjin
2020-05-01
Rows per page Showing 1–12 of 12
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 25 September 2026. https://priyalifescience.com/clinical-trials-china/city/zhoukou

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 12 of those studies with a site in Zhoukou.

How many clinical trials are recruiting in Zhoukou?

6 of the 12 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 4 have not yet opened recruitment, 2 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Zhoukou), 12 studies
PhaseStudiesRecruitingShare
Observational3125%
Phase 23225%
Phase 43225%
Not applicable2016.7%
Phase 3118.3%

Most active sponsors

Lead sponsors with the most studies (Zhoukou)
Lead sponsorStudiesRecruiting
Institute of Hematology & Blood Diseases Hospital, China32
Capital Medical University21
Xuhua Duan20
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.10
China National Center for Cardiovascular Diseases11
Second Affiliated Hospital of Soochow University11
Sir Run Run Shaw Hospital10
Southwest Hospital, China11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.